Hester Biosciences Management
Management criteria checks 3/4
Hester Biosciences' CEO is Rajiv Gandhi, appointed in Mar 2005, has a tenure of 19.67 years. total yearly compensation is ₹37.07M, comprised of 51.4% salary and 48.6% bonuses, including company stock and options. directly owns 10.47% of the company’s shares, worth ₹2.37B. The average tenure of the management team and the board of directors is 3.6 years and 4.6 years respectively.
Key information
Rajiv Gandhi
Chief executive officer
₹37.1m
Total compensation
| CEO salary percentage | 51.4% |
| CEO tenure | 19.7yrs |
| CEO ownership | 10.5% |
| Management average tenure | 3.6yrs |
| Board average tenure | 4.6yrs |
Recent management updates
Hester Biosciences Limited's (NSE:HESTERBIO) CEO Compensation Looks Acceptable To Us And Here's Why
Aug 23
Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Jan 11
How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?
Aug 07Recent updates
Hester Biosciences Limited's (NSE:HESTERBIO) CEO Compensation Looks Acceptable To Us And Here's Why
Aug 23What Hester Biosciences Limited's (NSE:HESTERBIO) 26% Share Price Gain Is Not Telling You
Jul 27Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price
Jun 12Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00
Aug 01Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?
Mar 03Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?
Feb 13What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?
Jan 26Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Jan 11Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 25Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 10These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Nov 25How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?
Nov 10If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns
Oct 26What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Oct 05Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?
Sep 14These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Aug 25How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?
Aug 07Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?
Jul 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹235m |
| Jun 30 2024 | n/a | n/a | ₹194m |
| Mar 31 2024 | ₹37m | ₹19m | ₹189m |
| Dec 31 2023 | n/a | n/a | ₹185m |
| Sep 30 2023 | n/a | n/a | ₹257m |
| Jun 30 2023 | n/a | n/a | ₹285m |
| Mar 31 2023 | ₹41m | ₹19m | ₹266m |
| Dec 31 2022 | n/a | n/a | ₹298m |
| Sep 30 2022 | n/a | n/a | ₹271m |
| Jun 30 2022 | n/a | n/a | ₹308m |
| Mar 31 2022 | ₹48m | ₹20m | ₹393m |
| Dec 31 2021 | n/a | n/a | ₹413m |
| Sep 30 2021 | n/a | n/a | ₹451m |
| Jun 30 2021 | n/a | n/a | ₹412m |
| Mar 31 2021 | ₹52m | n/a | ₹344m |
| Dec 31 2020 | n/a | n/a | ₹275m |
| Sep 30 2020 | n/a | n/a | ₹267m |
| Jun 30 2020 | n/a | n/a | ₹265m |
| Mar 31 2020 | ₹39m | n/a | ₹292m |
| Dec 31 2019 | n/a | n/a | ₹396m |
| Sep 30 2019 | n/a | n/a | ₹409m |
| Jun 30 2019 | n/a | n/a | ₹413m |
| Mar 31 2019 | ₹21m | ₹20m | ₹416m |
| Mar 31 2018 | ₹24m | ₹19m | ₹256m |
Compensation vs Market: Rajiv's total compensation ($USD439.76K) is above average for companies of similar size in the Indian market ($USD196.14K).
Compensation vs Earnings: Rajiv's compensation has been consistent with company performance over the past year.
CEO
Rajiv Gandhi (62 yo)
19.7yrs
Tenure
₹37,070,000
Compensation
Mr. Rajiv Dinesh Gandhi serves as Independent Director for Steelcast Limited since January 23, 2023. Mr. Gandhi joined the Steelcast Limited on January 23, 2023. He has been the Executive Chief Executive O...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive CEO | 19.7yrs | ₹37.07m | 10.47% ₹ 2.4b | |
| Executive Director | no data | ₹5.40m | no data | |
| Chief Financial Officer | no data | no data | no data | |
| Senior VP of Sales & Marketing and COO | less than a year | no data | no data | |
| Company Secretary & Compliance Officer | 6.5yrs | no data | no data | |
| CEO of Hester Biosciences Nepal Private Limited | no data | no data | no data | |
| Consultant | no data | no data | no data |
3.6yrs
Average Tenure
62yo
Average Age
Experienced Management: HESTERBIO's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive CEO | 37.6yrs | ₹37.07m | 10.47% ₹ 2.4b | |
| Executive Director | 3.1yrs | ₹5.40m | no data | |
| Non-Executive Non-Independent Chairman | 31.9yrs | ₹250.00k | 4.69% ₹ 1.1b | |
| Non-Executive & Non-Independent Director | 25.6yrs | no data | 4.74% ₹ 1.1b | |
| Non Executive Non Independent Director | 37.6yrs | ₹270.00k | 8.2% ₹ 1.9b | |
| Non-Executive Independent Director | 3.1yrs | ₹150.00k | no data | |
| Alternate Director | 8.5yrs | ₹150.00k | 8.19% ₹ 1.9b | |
| Non-Executive Independent Director | 4.6yrs | ₹480.00k | no data | |
| Non-Executive Independent Director | 4.6yrs | ₹500.00k | no data | |
| Non-Executive & Independent Director | 1.4yrs | ₹150.00k | no data | |
| Non-Executive & Independent Director | 1.4yrs | ₹100.00k | no data |
4.6yrs
Average Tenure
58.5yo
Average Age
Experienced Board: HESTERBIO's board of directors are considered experienced (4.6 years average tenure).